Zomedica Corp (AMEX: ZOM) on Tuesday, plunged -1.23% from the previous trading day, before settling in for the closing price of $0.13. Within the past 52 weeks, ZOM’s price has moved between $0.12 and $0.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 78.21% annually for the last half of the decade. The company achieved an average annual earnings per share of -37.14%. With a float of $962.66 million, this company’s outstanding shares have now reached $979.95 million.
In an organization with 144 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 55.24%, operating margin of -143.14%, and the pretax margin is -232.24%.
Zomedica Corp (ZOM) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Zomedica Corp is 1.76%, while institutional ownership is 8.27%. The most recent insider transaction that took place on Nov 08 ’24, was worth 18,450. In this transaction COO of this company bought 150,000 shares at a rate of $0.12, taking the stock ownership to the 400,000 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Director bought 100,000 for $0.12, making the entire transaction worth $12,100. This insider now owns 2,425,000 shares in total.
Zomedica Corp (ZOM) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -37.14% per share during the next fiscal year.
Zomedica Corp (AMEX: ZOM) Trading Performance Indicators
Zomedica Corp (ZOM) is currently performing well based on its current performance indicators. A quick ratio of 10.15 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.06, a number that is poised to hit -0.01 in the next quarter and is forecasted to reach -0.03 in one year’s time.
Technical Analysis of Zomedica Corp (ZOM)
Let’s dig in a bit further. During the last 5-days, its volume was 4.43 million. That was inferior than the volume of 4.81 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 20.68%. Additionally, its Average True Range was 0.01.
During the past 100 days, Zomedica Corp’s (ZOM) raw stochastic average was set at 22.09%, which indicates a significant decrease from 29.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.45% in the past 14 days, which was higher than the 44.62% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1279, while its 200-day Moving Average is $0.1397. However, in the short run, Zomedica Corp’s stock first resistance to watch stands at $0.1305. Second resistance stands at $0.1327. The third major resistance level sits at $0.1345. If the price goes on to break the first support level at $0.1265, it is likely to go to the next support level at $0.1247. Assuming the price breaks the second support level, the third support level stands at $0.1225.
Zomedica Corp (AMEX: ZOM) Key Stats
Market capitalization of the company is 125.63 million based on 979,950K outstanding shares. Right now, sales total 25,190 K and income totals -34,530 K. The company made 7,000 K in profit during its latest quarter, and -6,700 K in sales during its previous quarter.
